Strategic Collaborations iBET has a strong history of international partnerships with major pharma players (e.g., Bayer, Novartis, Merck, Abbvie, Sanofi, AstraZeneca, GSK) and collaborations like Vector BioPharma. This indicates receptiveness to co-development, technology transfer, and joint research ventures that can open doors for sponsored programs, contract research, and strategic alliances.

Bioprocess & Analytics With capabilities spanning bioprocess development for complex biologics and a GMP certified Analytical Services Unit plus a Mass Spectrometry Unit, iBET can be a target for contract research, analytical testing services, process optimization partnerships, and scale-up support for biotech programs in pharma and biotech firms.

Access to Expertise A workforce of over 250 researchers including around 110 PhDs positions iBET as a rich source of scientific expertise in vaccines, recombinant proteins, viral vectors, gene and cell therapies, and in vitro models. This can be leveraged for consulting, sponsored research, and expert advisory engagements.

Funding & Projects iBET has coordinated 30+ international projects and led work-packages in 100+ EU-funded initiatives, signaling strong program management, grant-ready collaboration potential, and access to EU-funded funding routes for industry partners seeking to co-finance R&D.

Market Positioning The organization’s integration of Food and Health, environmental process innovations, and a focus on sustainable, energy-saving bioprocesses provides cross-sector selling points for food safety analytics, water/food pathogen testing, and bio-based product development collaborations with potential customers in life sciences and environmental tech.